| RS193253559 |
PEX12
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 3A (Zellweger), Inborn genetic diseases |
| RS193257576 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS193261408 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1932632616 |
PDGFB
|
Health Risk |
Likely pathogenic |
Basal ganglia calcification, idiopathic |
| RS193265138 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS193267972 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited glutathione synthetase deficiency, Inborn genetic diseases |
| RS193271416 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS193272250 |
ETS1
|
Health Risk |
Likely pathogenic |
ETS1-related disorder, ETS1-related disorder |
| RS193275092 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1932758693 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1932758837 |
MN1
|
Health Risk |
Likely pathogenic |
MN1 C-terminal truncation (MCTT) syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1932759453 |
MN1
|
Health Risk |
Likely pathogenic |
MN1 C-terminal truncation (MCTT) syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS193284839 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS193291760 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1932931896 |
CFAP44
|
Health Risk |
Likely pathogenic |
CFAP44-related disorder, CFAP44-related disorder |
| RS1932981715 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS193298428 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Cardiovascular phenotype |
| RS1933016162 |
GK
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn glycerol kinase deficiency |
| RS193302438 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdomyolysis, susceptibility to |
| RS193302847 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302848 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, Retinal dystrophy |
| RS193302849 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, Rod-cone dystrophy |
| RS193302852 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS193302853 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302854 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302855 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302856 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302858 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302859 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS193302861 |
SLITRK1
|
Health Risk |
Pathogenic |
Trichotillomania, Tourette syndrome |
| RS193302864 |
EFEMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cutis laxa, autosomal recessive |
| RS193302865 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS193302866 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS193302867 |
EFEMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cutis laxa, autosomal recessive |
| RS193302868 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS193302869 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS193302870 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS193302871 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS193302872 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS193302873 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS193302876 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS193302877 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS193302878 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302879 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302880 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302881 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS193302882 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Congenital disorder of glycosylation |
| RS193302883 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS193302884 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302885 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302887 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302888 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302889 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type I |
| RS193302890 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302891 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS193302892 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302893 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Congenital disorder of glycosylation |
| RS193302894 |
SLC37A4
|
Health Risk |
Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS193302903 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glycogen storage disease type 1 due to SLC37A4 mutation |
| RS193302904 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302905 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302906 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302907 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302908 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302909 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302910 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302911 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302912 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302913 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193302914 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS193303018 |
MT-TL1
|
Health Risk |
Likely pathogenic |
Myelodysplastic syndrome, MELAS syndrome |
| RS193303102 |
NOBOX
|
Health Risk |
Pathogenic |
Premature ovarian failure 5, Premature ovarian failure 5 |
| RS193303103 |
NOBOX
|
Health Risk |
Pathogenic |
Premature ovarian failure 5, Premature ovarian failure 5 |
| RS193303104 |
NOBOX
|
Health Risk |
Pathogenic |
Premature ovarian failure 5, Premature ovarian failure 5 |
| RS1933151965 |
ZRSR2
|
Health Risk |
Likely pathogenic |
Severe hydrocephalus, Median cleft lip and palate |
| RS1933190705 |
MID2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 101 |
| RS1933254254 |
CLCN5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1933254834 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS1933255436 |
CLCN5
|
Health Risk |
Pathogenic |
Proteinuria, low molecular weight |
| RS1933257247 |
CLCN5
|
Health Risk |
Likely pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS1933302820 |
MN1
|
Health Risk |
Conflicting classifications of pathogenicity |
CEBALID syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1933304057 |
MN1
|
Health Risk |
Likely pathogenic |
MN1 C-terminal truncation (MCTT) syndrome, MN1 C-terminal truncation (MCTT) syndrome |
| RS1933308051 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1933329681 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1933335869 |
NSDHL
|
Health Risk |
Likely pathogenic |
— |
| RS1933337210 |
NSDHL
|
Health Risk |
Pathogenic |
— |
| RS1933378166 |
MN1
|
Health Risk |
Pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS1933378481 |
CLCN5
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS1933380245 |
CLCN5
|
Health Risk |
Pathogenic |
Dent disease type 1, Dent disease type 1 |
| RS1933387717 |
MN1
|
Health Risk |
Likely pathogenic |
— |
| RS1933401338 |
MN1
|
Health Risk |
Likely pathogenic |
— |
| RS1933405005 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1933408913 |
PHEX
|
Health Risk |
Pathogenic |
Nonpapillary renal cell carcinoma, Hypophosphatemic rickets |
| RS1933409121 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1933458497 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1933531491 |
SLC9A9
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1933652537 |
CLCN5
|
Health Risk |
Pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS1933713383 |
CLCN5
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, X-linked recessive nephrolithiasis with renal failure |
| RS1933773048 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1933775645 |
PHEX
|
Health Risk |
Pathogenic |
— |